BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8640351)

  • 1. Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats.
    Whiteaker P; Garcha HS; Wonnacott S; Stolerman IP
    Br J Pharmacol; 1995 Oct; 116(3):2097-105. PubMed ID: 8640351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
    Clarke PB; Reuben M
    Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nicotinic receptor agonists (-)-nicotine and isoarecolone differ in their effects on dopamine release in the nucleus accumbens.
    Mirza NR; Pei Q; Stolerman IP; Zetterström TS
    Eur J Pharmacol; 1996 Jan; 295(2-3):207-10. PubMed ID: 8720585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural effects of the nicotinic agonists N-(3-pyridylmethyl)pyrrolidine and isoarecolone in rats.
    Reavill C; Waters JA; Stolerman IP; Garcha HS
    Psychopharmacology (Berl); 1990; 102(4):521-8. PubMed ID: 2096409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine-evoked [3H]5-hydroxytryptamine release from rat striatal synaptosomes.
    Reuben M; Clarke PB
    Neuropharmacology; 2000 Jan; 39(2):290-9. PubMed ID: 10670424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (S)-(-)-Cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke [3H]dopamine release from rat striatal slices in a calcium-dependent manner.
    Dwoskin LP; Teng L; Buxton ST; Crooks PA
    J Pharmacol Exp Ther; 1999 Mar; 288(3):905-11. PubMed ID: 10027825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of bupropion on nicotinic receptor-evoked [(3)H]dopamine release from rat striatal synaptosomes and slices.
    Sidhpura N; Redfern P; Wonnacott S
    Eur J Pharmacol; 2007 Jul; 567(1-2):102-9. PubMed ID: 17477919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of isoarecolone, a nicotinic receptor agonist in rodent models of nicotine dependence.
    Shoaib M
    Psychopharmacology (Berl); 2006 Oct; 188(2):252-7. PubMed ID: 16932923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinic modulation of [3H]dopamine release from striatal synaptosomes: pharmacological characterisation.
    Rapier C; Lunt GG; Wonnacott S
    J Neurochem; 1990 Mar; 54(3):937-45. PubMed ID: 2303820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinic receptors modulating somatodendritic and terminal dopamine release differ pharmacologically.
    Reuben M; Boye S; Clarke PB
    Eur J Pharmacol; 2000 Mar; 393(1-3):39-49. PubMed ID: 10770996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoarecolone can inhibit nicotine binding and produce nicotine-like discriminative stimulus effects in rats.
    Reavill C; Spivak CE; Stolerman IP; Waters JA
    Neuropharmacology; 1987 Jul; 26(7A):789-92. PubMed ID: 3627386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different nicotinic acetylcholine receptor subtypes mediating striatal and prefrontal cortical [3H]dopamine release.
    Cao YJ; Surowy CS; Puttfarcken PS
    Neuropharmacology; 2005 Jan; 48(1):72-9. PubMed ID: 15617729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum.
    Clarke PB; Reuben M; el-Bizri H
    Br J Pharmacol; 1994 Mar; 111(3):695-702. PubMed ID: 8019748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro.
    Rousseau SJ; Jones IW; Pullar IA; Wonnacott S
    Neuropharmacology; 2005 Jul; 49(1):59-72. PubMed ID: 15992581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.
    Teng L; Crooks PA; Sonsalla PK; Dwoskin LP
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1432-44. PubMed ID: 9067333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desensitization of nicotine-stimulated [3H]dopamine release from mouse striatal synaptosomes.
    Grady SR; Marks MJ; Collins AC
    J Neurochem; 1994 Apr; 62(4):1390-8. PubMed ID: 8133269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro.
    el-Bizri H; Clarke PB
    Br J Pharmacol; 1994 Feb; 111(2):406-13. PubMed ID: 8004384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
    Clarke PB; Reuben M
    Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation.
    Rapier C; Lunt GG; Wonnacott S
    J Neurochem; 1988 Apr; 50(4):1123-30. PubMed ID: 3346670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrodotoxin-sensitivity of nicotine-evoked dopamine release from rat striatum.
    Marshall D; Soliakov L; Redfern P; Wonnacott S
    Neuropharmacology; 1996; 35(11):1531-6. PubMed ID: 9025100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.